Publications: New Psychoactive Substances

Synthetic Drugs in East and Southeast Asia. Latest developments and challenges (pdf)

NPS Ecstasy Metamphetamine

Synthetic Drugs in East and Southeast Asia. Latest developments and challenges

As of December 2020, a total of 485 different NPS have been identified in East and Southeast Asia. Though the number of newly identified NPS each year in the region has continued to decline since 2015, this may, in part, be due to the limited forensic capacity of some countries in the region to identify these substances.

Synthetic cannabinoids dominate the regional NPS market in East and Southeast Asia. China, Indonesia, Malaysia, Singapore, the Republic of Korea, and Viet Nam reported that synthetic cannabinoids were the most identified NPS in samples analysed. The Republic of Korea and Indonesia also reported increases in the amount of synthetic cannabinoids seized in 2020 compared to 2019.

Проблемы НПВ в Республике Казахстан: эпидемиологические и клинические аспекты (pdf)

Медицинский университет Семей

Проблемы НПВ в Республике Казахстан: эпидемиологические и клинические аспекты

Prevalence of new psychoactive substances addiction: a hospital-based cross-sectional study (pdf)

Mariya Prilutskaya (Department of Personalized Medicine and Pediatrics, Pavlodar Branch of Semey Medical University)

Oleg Yussopov (Epidemiology Department, Monitoring Center on Alcohol and Drugs, Pavlodar)

Nikolay Negay (Scientific and Clinical Department, Republican Scientific and Practical Center of Mental Health)

Prevalence of new psychoactive substances addiction: a hospital-based cross-sectional study

New Psychoactive Substances (NPS): the EU Early Warning System (EWS) perspective (pdf)

Rachel Christie (EMCDDA)

New Psychoactive Substances (NPS): the EU Early Warning System (EWS) perspective

•Decrease in the number of new substances identified for the first time in 2016 and 2017

•However, a large increase observed in:

•Availability of NPS in Europe

•Detections reported by law enforcement agencies

•Serious adverse events i.e. non-fatal intoxications, deaths and other harms

•Consumer groups of NPS have broadened

•Trend towards highly potent substances

•Growing interactions between the NPS and the established illicit drug market

Обзор ситуации с НПВ в Германии и Европе. Воздействие этих веществ (pdf)

Обзор ситуации с НПВ в Германии и Европе. Воздействие этих веществ.

Программа по предотвращению распространения наркотиков в Центральной Аз

Региональная конференция по новым психоактивным веществам

Узбекистан: профилактика распространения НПВ (pdf)

Узбекистан: профилактика распространения НПВ

Первые случаи выявления НПВ начали регистрироваться с конца 2014 года, однако нормативно-правовая база (национальные списки контролируемых веществ) не позволяли квалифицировать деяния как незаконный оборот наркотических средств
12 ноября 2015 года – принято постановление Кабинета Министров №330, Список I дополнен 80 наименованиями встречающимися в регионе и России разновидностями синтетических каннабиноидов

New psychoactive substances and drug policy challenges (pdf)

Meropi Tzanetakis (University of Essex, Department of Sociology & University of Vienna, Department of Political Science)

New psychoactive substances and drug policy challenges

NPS are proliferating at an unprecedented rate
Pose a significant risk to public health
Challenge to international drug control system and to national systems
Limited information available

NPS: обзор и лучшая практика в области политики борьбы с наркотиками, сбора данных, профилактики и лечения. Разделение событий от государств-членов Средней Азии и Европейского союза. (pdf)

Штефан Валхер

NPS: обзор и лучшая практика в области политики борьбы с наркотиками, сбора данных, профилактики и лечения. Разделение событий от государств-членов Средней Азии и Европейского союза.

Региональный семинар
6-7 февраля 2019
Бишкек, Кыргызская Республика

Наркологическая практика по НПВ в Кыргызской Республике (pdf)

Бакирова Ж.К.-зав. организационно-методического отдела РЦН МЗКР

Наркологическая практика по НПВ в Кыргызской Республике

Региональная конференция по НПВ: обзор и передовой опыт в области наркополитики, сбора данных, профилактики и лечения Наркозависимости. Обмен опытом между странами Центральной Азии и Европейского союза

Проблемы потребления новых психоактивных веществ в Республике Казахстан (pdf)

Б.Ж. Нуралиев (Республиканский научно-практический центр психического здоровья Министерства здравоохранения Республики Казахстан)

Проблемы потребления нпв в Республике Казахстан

Проблемы потребления новых психоактивных веществ в Республике Казахстан

Assessing patterns of use of new psychoactive substances (pdf)

Noelia Salgueiro-Gonzalez

Assessing patterns of use of new psychoactive substances

The NPS-Euronet project.

Monitor the extent, pattern of use and circulation in Europe of the selected NPS by using quantitative, analysis of wastewater and urine samples.

Urine collected from hospital emergency rooms and forensic cases
Wastewater from sewage of major European cities
Wastewater and pooled urine from music festival venues

Prevalence of NPS use among the European general population (adults and school students) (pdf)

Julian Vincente

NPS Europe EMCDDA

Prevalence of NPS use among the European general population (adults and school students)

Structured session: An epidemiological overview of New Psychoactive Substances use in Europe (NPS), towards a public health approach.

Findings from the Global State of Harm Reduction 2018 Harm reduction for stimulant use (pdf)

Sam Shirley-Beavan (HRI)

NPS harm reduction opioid use

Findings from the Global State of Harm Reduction 2018 Harm reduction for stimulant use

Trends in stimulant use worldwide:

Rising prevalence in North America, Asia and sub-Saharan Africa
An end to a long term decline in Western Europe
High prevalence of use of cocaine and its derivatives in Latin America and the Caribbean
Despite this, harm reduction for stimulant use is less established than harm reduction for opioid use

Patterns of NPS Consumption and Perceived Risks and Benefits: Results of Online Survey in Georgia (pdf)

David Subeliani (Ilia state University, Tbilisi)

David Otiashvili (Addiction Research Centre – Alternative Georgia)

Patterns of NPS Consumption and Perceived Risks and Benefits: Results of Online Survey in Georgia

New Psychoactive Substances use in self-selected respondents of the population (pdf)

Artur Malczewski (National Bureau for Drug Prevention Poland)

Julian Vicente (EMCDDA)

Joao Matias (EMCDDA)

NPS Survey Europe

New Psychoactive Substances use in self-selected respondents of the population

The Global Drug Survey (GDS) (65 thousand participants worldwide answered questions concerning NPS)
I-TREND (2014) – the countries involved in the study: Poland, France, Czechia and Holland (2323 NPS users)
NPS transnational (2016) - the countries involving in the study: Germany, Hungary, Ireland, Holland, Poland and Portugal (2210 NPS users)
The second wave of the European Web Survey on Drugs 2017, the countries involved in the study: Austria, Belgium, Estonia, Finland, Italy, Latvia, Lithuania, Poland, Luxembourg and Cyprus (9805 respondents reported ever using NPS)

Research on the Use of New Psychoactive Substances and Challenges in Responding to It in Moldova and Belarus (pdf)

Eliza Kurcevic (EHRA)

Research on the Use of New Psychoactive Substances and Challenges in Responding to It in Moldova and Belarus

Research project ‘New Psychoactive Substance Use in Moldova and Belarus’, conducted in partnership between the Eurasian Harm Reduction Association (EHRA) and the School of Law, Swansea University, funded by the Global Challenges Research Fund. Principle Investigator Dr. Rick Lines of Swansea University

How does Ketamine use affect long term mental health and drug use outcomes? (pdf)

Maryem Grabski (University College London)

How does Ketamine use affect long term mental health and drug use outcomes?

A propensity score matching analysis from the Electronic Music Scene Survey

Drug Information and Monitoring system (DIMS) (pdf)

Laura Smit-Rigter (Trimbos Institute)

NPS Netherlands

Drug Information and Monitoring system (DIMS)

Lessons learned from 27 years of drug checking in the Netherlands.

DIMS organisation and goals

To know which recreational drugs are currently being used and what changes in drug use are seen over
time (monitoring).
Identifying possible additional health risks and initiating and performing warning campaigns (surveillance)

The counselors’ perspective on the use of crystal meth in a sexual context among men who have sex with men (pdf)

Valérie Aubut (Université du Québec)

NPS MSM Montreal

The counselors’ perspective on the use of crystal meth in a sexual context among men who have sex with men

Goals of working table

To gather principals actors concern by crystal meth use among MSM: researchers, counselors, managers, stakeholders and users.
To develop an update of the scientific literature around crystal meth, HIV risk, hepatites and other infections
To identify methamphetamine user’s needs in Montreal and identify needs for harm reduction interventions (both in terms of methamphetamine use and sexual practices
To develop projects based on evidences-based for crystal meth users and adapted to cultural reality in Montreal

Проблемы потребления новых психоактивных веществ – также и в Германии (pdf)

Katharina Schoett

Ingo Ilia Michels

Проблемы потребления нпв – также и в Германии

Число вновь обнаруженных новых веществ является лишь одной из нескольких мер, используемых Европейским центром мониторинга наркотиков и наркомании. Например, 423 (почти 70%) из 620 контролируемых в настоящее время новых психоактивных веществ были обнаружены на рынке наркотиков в 2015 году, в отличие от 365 в 2014 году и 299 в 2013 году. Это показывает, насколько сложным стал рынок в это время.